2021 - Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)
Date2021-01-14 - 2021-01-15
Deadline2021-01-04
VenueVirtual Seminar, USA - United States
KeywordsProcess validation; Q9 quality risk management; Ind clinical trial
Topics/Call fo Papers
Why these FDA Guidance/EU Guidelines for Industry - Process Validation is so important to the pharmaceutical and biotechnology industry.
What FDA segments are included and excluded within the "NEW" Process Validation.
Where does the Process Validation commence.
What are the Three Stages and Where They Apply within the NEW Process Validation.
How Stage 1 integrates with Phase 1.
The Validation approaches that are included within this Guidance document.
The Statutory and Regulatory Requirements for Process Validation.
An Introduction to Phase 1 Guidance for Industry and Its Application within the "NEW" Process Validation.
The Phase 1 Investigational Drug Requirements -- What is and What is NOT Required.
General Considerations for Process Validation - Stage 2 Process Qualification.
Regulatory Strategies for Phase 2 and 3 and their Incorporation within Stages 1 and 2.
General Considerations for Process Validation - Stage 3 Continued Process Verification.
A Review of EU Annex 15 and its Comparison to FDA’s Process Validation Guidance.
What FDA segments are included and excluded within the "NEW" Process Validation.
Where does the Process Validation commence.
What are the Three Stages and Where They Apply within the NEW Process Validation.
How Stage 1 integrates with Phase 1.
The Validation approaches that are included within this Guidance document.
The Statutory and Regulatory Requirements for Process Validation.
An Introduction to Phase 1 Guidance for Industry and Its Application within the "NEW" Process Validation.
The Phase 1 Investigational Drug Requirements -- What is and What is NOT Required.
General Considerations for Process Validation - Stage 2 Process Qualification.
Regulatory Strategies for Phase 2 and 3 and their Incorporation within Stages 1 and 2.
General Considerations for Process Validation - Stage 3 Continued Process Verification.
A Review of EU Annex 15 and its Comparison to FDA’s Process Validation Guidance.
Other CFPs
- Quality Control Laboratory Compliance - cGMPs and GLPs
- Complete 1099, TIN Matching, B-Notice, FATCA and Nonresident Alien 1042-S Compliance Update
- 16th Euro-Global Gastroenterology Conference
- 36th International Conference on Dental and Oral Health
- 3rd International Conference on Virtual Reality and Image Processing (VRIP 2021)
Last modified: 2020-12-07 21:08:14